FOXC2 and cancer: The first observation was in nasopharyngeal carcinoma, in which FOXC2 increases glycolysis in cancer cells via the FOXC2-YAP (Yes-Associated Protein) axis to up-regulate hexokinase 2 and ultimately facilitates tumor survival and progression [44].